Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MYO18B antisense RNA 1 (MYO18B-AS1) is a human long non-coding RNA (lncRNA) gene located on chromosome 22 (22q) that is transcribed antisense to the protein-coding MYO18B gene[1][3][5]. As with many lncRNAs, the detailed function is not well established, but it may be involved in gene or chromatin regulation and has associations with rare congenital syndromes including Klippel-Feil syndrome linked to myopathies and facial dysmorphism[5]. There is currently no evidence to support MYO18B-AS1 as a classic therapeutic target, receptor, or enzyme, nor are there known drug interactions or established biomarker or safety data for clinical targeting.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MYO18B antisense RNA 1 (MYO18B-AS1).